Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4695041015 | Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4695043017 | Artemether 20 mg and lumefantrine 120 mg tablet for oral suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5644501000052118 | artemeter 20 mg och lumefantrin 120 mg, tablett till oral suspension | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Is a | Artemether and lumefantrine only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has manufactured dose form | Tablet for conventional release oral suspension (dose form) | true | Inferred relationship | Some | ||
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Some | ||
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has precise active ingredient | Lumefantrine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Lumefantrine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has precise active ingredient | Artemether (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Artemether (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets